Correlation Between Tscan Therapeutics and Achieve Life

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Achieve Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Achieve Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Achieve Life Sciences, you can compare the effects of market volatilities on Tscan Therapeutics and Achieve Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Achieve Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Achieve Life.

Diversification Opportunities for Tscan Therapeutics and Achieve Life

0.57

Correlation Coefficient

Tscan Therapeutics  Achieve Life

Very weak diversification

The 3 months correlation between Tscan and Achieve is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Achieve Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achieve Life Sciences and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Achieve Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achieve Life Sciences has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Achieve Life go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Achieve Life

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Achieve Life. But the stock apears to be less risky and, when comparing its historical volatility, Tscan Therapeutics is 1.02 times less risky than Achieve Life. The stock trades about -0.27 of its potential returns per unit of risk. The Achieve Life Sciences is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  380.00  in Achieve Life Sciences on December 26, 2024 and sell it today you would lose (94.00) from holding Achieve Life Sciences or give up 24.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  Achieve Life Sciences

Tscan Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Achieve Life Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Achieve Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Tscan Therapeutics and Achieve Life

The main advantage of trading using opposite Tscan Therapeutics and Achieve Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Achieve Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achieve Life will offset losses from the drop in Achieve Life's long position.

The idea behind Tscan Therapeutics and Achieve Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.